Stock Earnings

Question 1

What are Hisamitsu Pharmaceutical Co Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Hisamitsu Pharmaceutical Co Inc has a total asset of $343,068, Net profit of $21,758

Question 2

What are the key financial ratios for HTSUF?

Accepted Answer

Hisamitsu Pharmaceutical Co Inc's Current ratio is 5.17, has a Net margin is 13.94, sales per share of $2,116.23.

Question 3

How is Hisamitsu Pharmaceutical Co Inc's revenue broken down by segment or geography?

Accepted Answer

Hisamitsu Pharmaceutical Co Inc largest revenue segment is Pharmaceuticals, at a revenue of 152,654,000,000 in the most earnings release.For geography, Japan is the primary market for Hisamitsu Pharmaceutical Co Inc, at a revenue of 82,364,000,000.

Question 4

Is Hisamitsu Pharmaceutical Co Inc profitable?

Accepted Answer

yes, according to the latest financial statements, Hisamitsu Pharmaceutical Co Inc has a net profit of $21,758

Question 5

Does Hisamitsu Pharmaceutical Co Inc have any liabilities?

Accepted Answer

yes, Hisamitsu Pharmaceutical Co Inc has liability of 66,242

Question 6

How many outstanding shares for Hisamitsu Pharmaceutical Co Inc?

Accepted Answer

Hisamitsu Pharmaceutical Co Inc has a total outstanding shares of 72.96

Breakdown	TTM	02/28/2025	02/29/2024	02/28/2023	02/28/2022	02/28/2021
Revenue	155,493	156,006	141,706	128,330	120,193	114,510
Revenue Growth (YoY)	4%	10%	10%	7%	5%	-19%
Cost of Revenue	62,614	64,810	62,735	55,630	50,126	45,337
Gross Profit	92,879	91,196	78,971	72,700	70,067	69,173
Selling, General & Admin	74,861	61,397	57,189	51,314	50,117	47,735
Research & Development	--	10,903	8,614	9,785	10,613	10,766
Operating Expenses	74,862	72,301	65,804	61,101	60,730	58,502
Other Non Operating Income (Expenses)	673	731	453	198	418	171
Pretax Income	25,620	28,687	19,186	16,113	12,956	12,197
Income Tax Expense	5,491	6,385	4,754	3,987	3,093	2,764
Net Income	19,682	21,758	13,969	11,742	9,658	9,250
Net Income Growth	34%	56%	19%	22%	4%	-51%
Shares Outstanding (Diluted)	71.91	73.71	77	79.4	81.27	81.78
Shares Change (YoY)	-2%	-4%	-3%	-2%	-1%	-1%
EPS (Diluted)	273.68	295.15	181.4	147.87	118.83	113.1
EPS Growth	37%	63%	23%	24%	5%	-50%
Free Cash Flow	8,354	4,991	5,151	4,820	15,006	1,900
Free Cash Flow Per Share	116.16	67.7	66.89	60.7	184.64	23.23
Gross Margin	59.73%	58.45%	55.72%	56.65%	58.29%	60.4%
Operating Margin	11.58%	12.11%	9.29%	9.03%	7.76%	9.31%
Profit Margin	12.65%	13.94%	9.85%	9.14%	8.03%	8.07%
Free Cash Flow Margin	5.37%	3.19%	3.63%	3.75%	12.48%	1.65%
EBITDA	24,860	25,230	18,339	16,551	13,658	14,750
EBITDA Margin	15.98%	16.17%	12.94%	12.89%	11.36%	12.88%
D&A For EBITDA	6,843	6,335	5,172	4,952	4,321	4,079
EBIT	18,017	18,895	13,167	11,599	9,337	10,671
EBIT Margin	11.58%	12.11%	9.29%	9.03%	7.76%	9.31%
Effective Tax Rate	21.43%	22.25%	24.77%	24.74%	23.87%	22.66%

Hisamitsu Pharmaceutical Co Inc (HTSUF) Price

HTSUF Stock Price Chart

HTSUF Income

Follow-Up Questions